Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Rouesse

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Journal of the National Cancer Institute|November 2, 1988
Interim report of phase II study of new nitrosourea S 10036 in disseminated malignant melanomaD Khayat, J P Bizzari, M Frenay, et al.
Acta Clinica Belgica. Supplementum|January 1, 1986
[Aminoglutethimide in advanced breast cancer. Multicenter trial comparing 500 mg and 1000 mg per day]J Bonneterre, H Coppens, L Mauriac, et al.
European Journal of Cancer & Clinical Oncology|May 1, 1987
VP-16 in advanced soft tissue sarcoma: a phase II study of the EORTC soft tissue and bone sarcoma groupP Dombernowsky, J Buesa, H M Pinedo, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
The use of recombinant human granulocyte-macrophage colony-stimulating factor with combination chemotherapy in the treatment of advanced adult soft-tissue sarcomas: early results from the EORTC Soft-Tissue and Bone Sarcoma GroupW P Steward, J Verweij, R Somers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1993
Granulocyte-macrophage colony-stimulating factor allows safe escalation of dose-intensity of chemotherapy in metastatic adult soft tissue sarcomas: a study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma GroupW P Steward, J Verweij, R Somers, et al.
Bulletin Du Cancer|January 1, 1989
[Response of bone metastases to medical treatment: definition of evaluation criteria and classification trials]D Belpomme, J P Droz, F N Marie, et al.
Seminars in Surgical Oncology|January 1, 1988
Review of the clinical trials activity of the Soft Tissue and Bone Sarcoma Group of the European Organization for Research and Treatment of CancerV H Bramwell, A Santoro, J Rouesse, et al.
International Journal of Cancer|January 15, 1984
Soft-tissue sarcomas of adults; study of pathological prognostic variables and definition of a histopathological grading systemM Trojani, G Contesso, J M Coindre, et al.
Cancer|November 15, 1986
Cardiac metastases. Case report on an isolated cardiac metastasis of a myxoid liposarcomaJ L Lagrange, P Despins, M Spielman, et al.
Cancer Treatment Reports|February 1, 1985
Phase II study of cisplatin in advanced osteogenic sarcoma. European Organization for Research on Treatment of Cancer Soft Tissue and Bone Sarcoma GroupM Gasparini, J Rouesse, A van Oosterom, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Journal of the National Cancer Institute|November 2, 1988
Interim report of phase II study of new nitrosourea S 10036 in disseminated malignant melanomaD Khayat, J P Bizzari, M Frenay, et al.
Acta Clinica Belgica. Supplementum|January 1, 1986
[Aminoglutethimide in advanced breast cancer. Multicenter trial comparing 500 mg and 1000 mg per day]J Bonneterre, H Coppens, L Mauriac, et al.
European Journal of Cancer & Clinical Oncology|May 1, 1987
VP-16 in advanced soft tissue sarcoma: a phase II study of the EORTC soft tissue and bone sarcoma groupP Dombernowsky, J Buesa, H M Pinedo, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
The use of recombinant human granulocyte-macrophage colony-stimulating factor with combination chemotherapy in the treatment of advanced adult soft-tissue sarcomas: early results from the EORTC Soft-Tissue and Bone Sarcoma GroupW P Steward, J Verweij, R Somers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1993
Granulocyte-macrophage colony-stimulating factor allows safe escalation of dose-intensity of chemotherapy in metastatic adult soft tissue sarcomas: a study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma GroupW P Steward, J Verweij, R Somers, et al.
Bulletin Du Cancer|January 1, 1989
[Response of bone metastases to medical treatment: definition of evaluation criteria and classification trials]D Belpomme, J P Droz, F N Marie, et al.
Seminars in Surgical Oncology|January 1, 1988
Review of the clinical trials activity of the Soft Tissue and Bone Sarcoma Group of the European Organization for Research and Treatment of CancerV H Bramwell, A Santoro, J Rouesse, et al.
International Journal of Cancer|January 15, 1984
Soft-tissue sarcomas of adults; study of pathological prognostic variables and definition of a histopathological grading systemM Trojani, G Contesso, J M Coindre, et al.
Cancer|November 15, 1986
Cardiac metastases. Case report on an isolated cardiac metastasis of a myxoid liposarcomaJ L Lagrange, P Despins, M Spielman, et al.
Cancer Treatment Reports|February 1, 1985
Phase II study of cisplatin in advanced osteogenic sarcoma. European Organization for Research on Treatment of Cancer Soft Tissue and Bone Sarcoma GroupM Gasparini, J Rouesse, A van Oosterom, et al.
Pageof 6